These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7731378)

  • 1. Endocrine effects in Asian postmenopausal women, treated with SH D 461 M and Prempak-C.
    Goh HH; McCarthy TG; Dramusic V; Costales A; Junge W; Ratnam SS
    Maturitas; 1995 Jan; 21(1):17-25. PubMed ID: 7731378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine effects in Asian postmenopausal women treated with SH D 461 M and Prempak-C.
    Goh HH; McCarthy TG; Dramusic V; Costales A; Junge W; Ratnam SS
    Maturitas; 1994 Dec; 20(2-3):165-73. PubMed ID: 7715469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized cross-over study of a 21-day versus a 28-day hormone replacement therapy (HRT).
    McCarthy T; Dramusic V; Carter R; Costales A; Ratnam SS
    Maturitas; 1995 Jun; 22(1):13-23. PubMed ID: 7666812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two different progestins (cyproterone acetate and norgestrel), administered in a cyclical estradiol valerate regimen, on markers of bone turnover.
    Prelević GM; Beljić T; Balint-Perić L; Petrović J; Elliesen J
    Gynecol Endocrinol; 1994 Sep; 8(3):209-14. PubMed ID: 7847107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
    Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
    Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M; Hartmann B; Spinetti A; Mailand D; Rubino S; Albrecht A; Huber J; Petraglia F; Genazzani AR
    J Endocrinol Invest; 1996 Sep; 19(8):535-41. PubMed ID: 8905477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
    Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
    Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.
    Tuppurainen M; Heikkinen AM; Penttilä I; Saarikoski S
    Maturitas; 1995 Jun; 22(1):55-61. PubMed ID: 7666817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experiences with Climen in peri- and postmenopausal women].
    Husmann F
    Zentralbl Gynakol; 1997; 119(3):123-7. PubMed ID: 9173770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estradiol valerate/cyproterone acetate in the treatment of climacteric syndrome].
    Zivný J; Skrenková J
    Ceska Gynekol; 1996 Oct; 61(5):294-6. PubMed ID: 9004975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
    Vitale C; Fini M; Leonardo F; Rossini P; Cerquetani E; Onorati D; Rosano GM
    Maturitas; 2001 Dec; 40(3):239-45. PubMed ID: 11731185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effect of two hormonal preparations in postmenopausal women.
    Bissonnette F; Lussier-Cacan S; Fugère P; Bérubé S
    Maturitas; 1997 Jul; 27(3):275-84. PubMed ID: 9288700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study between estradiol valerate combined with cyproterone acetate, and conjugated equine estrogens combined with medroxyprogesterone acetate as hormone replacement therapy in climacteric].
    Carranza-Lira S; Martínez-Chéquer JC; Río de la Loza F; Murillo-Uribe A; Celis C
    Ginecol Obstet Mex; 2000 Nov; 68():442-7. PubMed ID: 11195956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: associations with sex hormone-binding globulin, estradiol, and estrone levels.
    Nachtigall LE; Raju U; Banerjee S; Wan L; Levitz M
    Menopause; 2000; 7(4):243-50. PubMed ID: 10914617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogens: therapeutic and adverse effects in early post-menopausal women.
    Marslew U; Riis B; Christiansen C
    Maturitas; 1991 Mar; 13(1):7-16. PubMed ID: 1830636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of a sequential combination of estradiol valerate and cyproterone acetate on the functional properties of the arterial wall in menopausal women].
    Mares P; Dauzat M; Abramovici Y; Deklunder G; Body G; Crepin G; Denis A; Favier M
    Gynecol Obstet Fertil; 2000; 28(7-8):509-17. PubMed ID: 10996962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hormone replacement therapy on insulin secretion and insulin sensitivity in postmenopausal diabetic women.
    Borissova AM; Tankova T; Kamenova P; Dakovska L; Kovacheva R; Kirilov G; Genov N; Milcheva B; Koev D
    Gynecol Endocrinol; 2002 Feb; 16(1):67-74. PubMed ID: 11915585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antiandrogens in hormone replacement therapy.
    Schneider HP
    Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term sequential treatment with combined estradiol valerate and cyproterone acetate in early postmenopause.
    Polatti F; Capuzzo E; Viazzo F; Colleoni R; Abbiati I; Nappi RE
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):49-53. PubMed ID: 9926892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy with estradiol valerate and cyproterone acetate: effects on endothelium-dependent vasodilatation and arterial wall compliance.
    Mares P; Dauzat M; Abramovici Y
    Maturitas; 2002 May; 42(1):45-53. PubMed ID: 12020979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.